In-Hospital Serum Uric Acid Change Predicts Adverse Outcome in Patients With Heart Failure

Bergamini, 2009, Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure, Eur J Heart Fail, 11, 444, 10.1093/eurjhf/hfp042 Chapman, 1997, Endothelial activation in monosodium urate monohydrate crystal-induced inflammation: in vitro and in vivo studies on the roles of tumor necrosis factor alpha and interleukin-1, Arthritis Rheum, 40, 955, 10.1002/art.1780400525 Doehner, 2002, Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies, Circulation, 105, 2619, 10.1161/01.CIR.0000017502.58595.ED Landmesser, 2002, Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase, Circulation, 106, 3073, 10.1161/01.CIR.0000041431.57222.AF Krishnan, 2009, Hyperuricemia and incident heart failure, Circ Heart Fail, 2, 556, 10.1161/CIRCHEARTFAILURE.108.797662 Virdis, 2020, Identification of the uric acid thresholds predicting an increased total and cardiovascular mortality over 20 years, Hypertension, 75, 302, 10.1161/HYPERTENSIONAHA.119.13643 Hoeper, 1999, Hyperuricaemia in patients with right or left heart failure, Eur Respir J, 13, 682, 10.1183/09031936.99.13368299 Borghi, 2014, Uricaemia and ejection fraction in elderly heart failure outpatients, Eur J Clin Invest, 44, 573, 10.1111/eci.12273 Cicero, 2014, Serum uric acid is inversely proportional to estimated stroke volume and cardiac output in a large sample of pharmacologically untreated subjects: data from the Brisighella Heart Study, Intern Emerg Med, 9, 655, 10.1007/s11739-013-1016-9 Anker, 2003, Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging, Circulation, 107, 1991, 10.1161/01.CIR.0000065637.10517.A0 Pascual-Figal, 2007, Hyperuricaemia and long-term outcome after hospital discharge in acute heart failure patients, Eur J Heart Fail, 9, 518, 10.1016/j.ejheart.2006.09.001 Hamaguchi, 2011, Hyperuricemia predicts adverse outcomes in patients with heart failure, Int J Cardiol, 151, 143, 10.1016/j.ijcard.2010.05.002 Filippatos, 2011, Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data, Eur Heart J, 32, 712, 10.1093/eurheartj/ehq473 Loenen, 1990, Serum uric acid correlates in elderly men and women with special reference to body composition and dietary intake (Dutch Nutrition Surveillance System), J Clin Epidemiol, 43, 1297, 10.1016/0895-4356(90)90095-7 Kaneko, 2017, Fructose suppresses uric acid excretion to the intestinal lumen as a result of the induction of oxidative stress by NADPH oxidase activation, Biochim Biophys Acta Gen Subj, 1861, 559, 10.1016/j.bbagen.2016.11.042 Maiuolo, 2016, Regulation of uric acid metabolism and excretion, Int J Cardiol, 213, 8, 10.1016/j.ijcard.2015.08.109 McAdams-DeMarco, 2013, A urate gene-by-diuretic interaction and gout risk in participants with hypertension: results from the ARIC study, Ann Rheum Dis, 72, 701, 10.1136/annrheumdis-2011-201186 Ben Salem, 2017, Drug-induced hyperuricaemia and gout, Rheumatology (Oxford), 56, 679 McKee, 1971, The natural history of congestive heart failure: the Framingham study, N Engl J Med, 285, 1441, 10.1056/NEJM197112232852601 Pencina, 2011, Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers, Stat Med, 30, 11, 10.1002/sim.4085 Ambrosy, 2013, Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial, Eur Heart J, 34, 835, 10.1093/eurheartj/ehs444 Domanski, 2006, Diuretic use, progressive heart failure, and death in patients in the DIG study, J Card Fail, 12, 327, 10.1016/j.cardfail.2006.03.006 Ahmed, 2006, Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods, Eur Heart J, 27, 1431, 10.1093/eurheartj/ehi890 Mullens, 2009, Importance of venous congestion for worsening of renal function in advanced decompensated heart failure, J Am Coll Cardiol, 53, 589, 10.1016/j.jacc.2008.05.068 Franse, 2000, Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP), J Hypertens, 18, 1149, 10.1097/00004872-200018080-00021 Savarese, 2013, Changes in serum uric acid levels and cardiovascular events: a meta-analysis, Nutr Metab Cardiovasc Dis, 23, 707, 10.1016/j.numecd.2013.03.001 Bosch, 2017, Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction, Eur J Heart Fail, 19, 1664, 10.1002/ejhf.873 Shoji, 2020, Long-term outcomes according to etiology may alter under different circumstances, JACC Heart Fail, 8, 83, 10.1016/j.jchf.2019.08.021 Costello-Boerrigter, 2006, Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure, Am J Physiol Renal Physiol, 290, F273, 10.1152/ajprenal.00195.2005 Cheungpasitporn, 2016, Short-term tolvaptan increases water intake and effectively decreases urinary calcium oxalate, calcium phosphate and uric acid supersaturations, J Urol, 195, 1476, 10.1016/j.juro.2015.11.027 Cappola, 2001, Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy, Circulation, 104, 2407, 10.1161/hc4501.098928 Cingolani, 2006, The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study, J Card Fail, 12, 491, 10.1016/j.cardfail.2006.05.005 Gotsman, 2012, Changes in uric acid levels and allopurinol use in chronic heart failure: association with improved survival, J Card Fail, 18, 694, 10.1016/j.cardfail.2012.06.528 Givertz, 2015, Effects of xanthine oxidase inhibition in hyperuricemic heart failure patients: the Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study, Circulation, 131, 1763, 10.1161/CIRCULATIONAHA.114.014536